| value |
{"aggregator_url":"https://www.nasdaq. {"aggregator_url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock","as_of":"2026-04-03T15:41:41.340615+00:00","canonical_url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_d52114e84e3edd3f","canonical_host":"nasdaq.com","canonical_is_aggregator":false,"canonical_url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-04T00:20:19.474885+00:00","extraction_method":"heuristic","fetched_description":"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.","fetched_title":"Here's Why Stryker (SYK) is a Strong Growth Stock | Nasdaq","final_url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock","html_truncated":false,"paywall_likely":false,"publisher_domain":"nasdaq.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock","source_event_id":"evt_6d07df1ef23c","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"ddb52974325510ab","kind":"new_listings","published_at":"2026-04-03T13:45:04+00:00","publisher_domain":"nasdaq.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["April 03, 2026"],"entities":[{"asset_class":"equity","name":"Stryker Corporation","relevance":"high","symbol":"SYK","type":"company"}],"event_type":"listing","information_gaps":["No specific growth rate or financial metrics provided for Stryker's performance.","Details on the Zacks Style Scores for Stryker are not fully disclosed."],"key_facts":["Stryker generated approximately 60% of sales from MedSurg & Neurotechnology and 40% from Orthopaedics in 2024.","About three-quarters of Stryker's revenue is derived from the United States."],"numeric_claims":[],"primary_claim":"Stryker (SYK) is rated #2 (Buy) on the Zacks Rank and has a VGM Score of B, suggesting it is a strong growth stock.","relevance_score":0.8,"sentiment":"positive","source_quality":"high","summary":"Stryker (SYK) is highlighted as a strong growth stock, rated #2 (Buy) on the Zacks Rank with a VGM Score of B, indicating potential for growth based on its performance in medical technology.","topics":["stock analysis","investment","growth stocks"]},"source":"Nasdaq Stocks","source_domain":"nasdaq.com","summary":"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.","tickers":["SYK"],"title":"Here's Why Stryker (SYK) is a Strong Growth Stock","url":"https://www.nasdaq.com/articles/heres-why-stryker-syk-strong-growth-stock"}... |